| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/13/2011 | US8017581 MSH-agonist tripeptide conjugates |
| 09/13/2011 | US8017580 Therapies for chronic renal failure |
| 09/13/2011 | US8017579 Treatment of viral infections |
| 09/13/2011 | US8017571 Peptides derived from human BPLP protein |
| 09/13/2011 | US8017559 Combinatorial libraries of proteins having the scaffold structure of C-type lectin-like domains |
| 09/13/2011 | US8017369 System and method of up-regulating bone morphogenetic proteins (BMP) gene expression in bone cells via the application of fields generated by specific and selective electric and electromagnetic signals |
| 09/13/2011 | US8017349 Human neuronal attachment factor-1 |
| 09/13/2011 | US8017343 Cytokine zalpha11 ligand antibodies and methods of use |
| 09/13/2011 | US8017341 Transcription factors |
| 09/13/2011 | US8017317 Equine herpes viruses (EHV) with immunomodulatory capacity; respiratory and neurological diseases |
| 09/13/2011 | US8017316 Methods and compositions for the identification of insect repellent compounds |
| 09/13/2011 | US8017315 Mitochondrial localization of MUC1 |
| 09/13/2011 | US8017313 Human G protein-coupled receptor and modulators thereof for the treatment of cardiovascular disorders |
| 09/13/2011 | US8017155 Immersing and soaking insoluble pore containing polymer into encapsulating solution containing active ingredient then initiating pore closing rearrangement by adjusting temperature and/or pH |
| 09/13/2011 | US8017134 Recombinant toxin fragments |
| 09/13/2011 | US8017131 Light chain that cleaves a neurosecretory protein; an HN domain that translocates the light chain across an endosome membrane and a substance P targeting moiety; the HC domain is removed or modified to reduce the targeting of the modified Clostridial toxin to the neuromuscular junction |
| 09/13/2011 | US8017130 Method of accelerated vaccination against Ebola viruses |
| 09/13/2011 | US8017127 Influenza immunogen and vaccine |
| 09/13/2011 | US8017125 Copolymers for suppression of autoimmune diseases, and methods of use |
| 09/13/2011 | CA2568352C Methods of using il-1 antagonists to treat autoinflammatory disease |
| 09/13/2011 | CA2525873C Tumor cytotoxicity induced by modulators of the cxcr4 receptor |
| 09/13/2011 | CA2465303C Compositions and methods for wt1 specific immunotherapy |
| 09/13/2011 | CA2429555C Position dependent recognition of gnn nucleotide triplets by zinc fingers |
| 09/13/2011 | CA2375535C Use of the bnm3 transcriptional activator to control plant embryogenesis and regeneration processes |
| 09/13/2011 | CA2356836C Novel streptococcus antigens |
| 09/13/2011 | CA2329120C Mara family helix-turn-helix domains and their methods of use |
| 09/13/2011 | CA2329060C Aav5 vector and uses thereof |
| 09/13/2011 | CA2224127C Flagellin gene, flac of campylobacter |
| 09/13/2011 | CA2220964C Alphavirus rna replicon systems |
| 09/13/2011 | CA2187535C Borrelia burgdorferi bacterin |
| 09/09/2011 | WO2011109511A2 Novel hiv-1 envelope glycoprotein |
| 09/09/2011 | WO2011108937A1 B-cell stimulating fusion proteins of an antigen with baff or april |
| 09/09/2011 | WO2011108628A1 Gastric cancer marker, and method for detecting gastric cancer |
| 09/09/2011 | WO2011108626A1 Gastric cancer marker, and method for detecting gastric cancer |
| 09/09/2011 | WO2011108281A1 Ischemic disorder-promoting polypeptide |
| 09/09/2011 | WO2011107992A2 Multimeric forms of therapeutic proteins and uses thereof |
| 09/09/2011 | WO2011107883A1 Avian group d rotavirus |
| 09/09/2011 | WO2011107808A1 Molecular engineering of a floral inducer for crop improvement |
| 09/09/2011 | WO2011107756A1 Protein expression system |
| 09/09/2011 | WO2011107591A1 Chimeric inhibitor molecules of complement activation |
| 09/09/2011 | WO2011107537A1 New plants with modified expression or activity of ethylene response factors |
| 09/09/2011 | WO2011107518A1 Selective enrichment of antibodies |
| 09/09/2011 | WO2011107505A1 Novel uses of elafin |
| 09/09/2011 | WO2011107456A1 Novel protein with structural homology to proteins with il-8-like chemokine fold and uses thereof |
| 09/09/2011 | WO2011107299A2 Method for the manufacture of recombinant dspa alpha1 |
| 09/09/2011 | WO2011106885A1 Oligomer-specific amyloid beta epitope and antibodies |
| 09/09/2011 | WO2011106882A1 Target of egr1 (toe1 ) polypeptides for inhibition of hiv |
| 09/09/2011 | WO2011106839A1 Skin cancer prevention and treatment |
| 09/09/2011 | WO2011080102A3 Glp-1 analogues and derivatives |
| 09/09/2011 | WO2011075611A8 Compositions and methods for non-invasive treatment of chronic complications of diabetes |
| 09/09/2011 | WO2011063770A3 Immunomodulatory polypeptides derived from il- 2 and their use thereof in the therapeutic of cancer and chronic infections |
| 09/09/2011 | WO2011060409A3 Cullen 5 as a regulator of hsp90 clients : a new target for drug development |
| 09/09/2011 | WO2011051964A3 Process for recombinant human growth hormone |
| 09/09/2011 | CA2792034A1 Avian rotavirus |
| 09/09/2011 | CA2791893A1 Marker for detecting gastric cancer and method for detecting gastric cancer |
| 09/09/2011 | CA2791850A1 Molecular clone of hiv-1 |
| 09/09/2011 | CA2791841A1 Chimeric inhibitor molecules of complement activation |
| 09/09/2011 | CA2791671A1 Marker for detecting gastric cancer and method for detecting gastric cancer |
| 09/09/2011 | CA2791538A1 Oligomer-specific amyloid beta epitope and antibodies |
| 09/09/2011 | CA2791386A1 Controlled delivery system |
| 09/09/2011 | CA2791383A1 Compositions and methods for targeted immunomodulatory antibodies and fusion proteins |
| 09/09/2011 | CA2791361A1 Method for producing soluble recombinant interferon protein without denaturing |
| 09/09/2011 | CA2791193A1 Polypeptide acting to enhance ischemic diseases |
| 09/09/2011 | CA2789938A1 Molecular engineering of a floral inducer for crop improvement |
| 09/08/2011 | US20110219464 Lung disease targets and uses thereof |
| 09/08/2011 | US20110218379 Epitopes derived from satb2 and uses thereof |
| 09/08/2011 | US20110218333 Internalizing ErbB2 antibodies |
| 09/08/2011 | US20110218332 Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| 09/08/2011 | US20110218327 METHOD FOR PROVIDING A β-LACTOGLOBULIN PRODUCT AND AN a-ENRICHED WHEY PROTEIN ISOLATE |
| 09/08/2011 | US20110218326 Plant-protein product and method for preparing the same |
| 09/08/2011 | US20110218325 Inhibitor of Endogenous Human Interferon-Gamma |
| 09/08/2011 | US20110218230 Natriuretic peptide related fragment in cardiovascular disease |
| 09/08/2011 | US20110218154 Histone deacetylases, and uses related thereto |
| 09/08/2011 | US20110218152 Compounds for stimulating p-glycoprotein function and uses thereof |
| 09/08/2011 | US20110218150 Antiangiogenic polypeptides and methods for inhibiting angiogenesis |
| 09/08/2011 | US20110218146 Adiponectin for treating pulmonary disease |
| 09/08/2011 | US20110218145 Antibodies to modified human igf-1/e peptides |
| 09/08/2011 | US20110218138 Pharmaceutical composition containing polypeptide fragments of serralysins |
| 09/08/2011 | US20110218122 Method of prognosing and diagnosing hereditary spastic paraplegia, mutant nucleic acid molecules and polypeptides |
| 09/08/2011 | US20110217767 Single-use Stationary Bioreactors and Mixing Vessels |
| 09/08/2011 | US20110217766 Methods of Producing Peptides in Plants and Peptides Produced Thereby |
| 09/08/2011 | US20110217460 Self-assembling, collagen-based material for corneal replacement |
| 09/08/2011 | US20110217338 HIV-1 Envelope Based Fragments |
| 09/08/2011 | US20110217334 Hypoallergenic molecules |
| 09/08/2011 | US20110217332 Chimpanzee Adenovirus Vaccine Carriers |
| 09/08/2011 | US20110217329 Vaccine |
| 09/08/2011 | US20110217325 T cell epitopes of the cyn d 1 allergen from bermuda grass pollen |
| 09/08/2011 | US20110217320 Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 09/08/2011 | US20110217316 GBS Toxin Receptor Compositions and Methods of Use |
| 09/08/2011 | US20110217314 Methods and Compositions for Modulating Apoptosis |
| 09/08/2011 | US20110217307 Synthetic peptides corresponding to overlapping neutralizing determinants in the cbd1 epitope induce broadly neutralizing antibodies |
| 09/08/2011 | US20110217292 Monoclonal antibodies against hmgb1 |
| 09/08/2011 | US20110217283 Stable galenic freeze-dried pharmaceutical preparation of recombinant carbohydrate-binding polypeptides |
| 09/08/2011 | DE102010009996A1 Verfahren zum Herstellen einer ersten codierenden Sequenz für Peptid, Protein zur Translationsverstärkung, codierende Sequenz, Expressionsvektor A method for preparing a first coding sequence for peptide, protein for translation gain coding sequence, expression vector |
| 09/08/2011 | DE102010009876A1 Vernetzer für Hydrogele Crosslinkers for hydrogels |
| 09/07/2011 | EP2363488A1 Postweaning multisystemic wasting syndrome virus from pigs |
| 09/07/2011 | EP2363487A2 A library of modified structural genes or capsid modified particles useful for the identification of viral clones with desired cell tropism |
| 09/07/2011 | EP2363478A1 Methods and compositions for inhibiting the function of polynucleotide sequences |
| 09/07/2011 | EP2363475A1 Screening method, composition containing substance selected by the screening method, and binding substance |
| 09/07/2011 | EP2363470A1 Method for introducing mutated gene, gene having mutation introduced therein, cassette for introducing mutation, vector for introducing mutation, and knock-in non-human mammal |